CVS Health announced plans to drop Eli Lilly's Zepbound from its preferred coverage ... and weight loss drugs Mounjaro and Zepbound. Lilly's stock fell 11% after the Thursday announcement.

CVS Health said it will significantly expand access to Novo Nordisk's blockbuster weight loss drug Wegovy for patients ...

Approximately 1 million Aetna members will need new coverage with the announcement that CVS will be leaving the ... For this iteration of the withdrawal, the loss of money surrounding the ...

Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said ... post that the closing announcement "is one of ...

Eli Lilly and Company's stock dropped 11% after CVS's Zepbound exclusion, but analysts see a mispricing opportunity. Click for why LLY growth remains strong.

Eli Lilly’s strong quarterly results were overshadowed by CVS’s decision to favour Novo Nordisk’s Wegovy over Zepbound.

CVS Health ( NYSE: CVS) on Thursday announced plans to discontinue operations in the individual health insurance business, also known as Obamacare, next year. The company made the announcement with ...

CVS Health on Thursday said it will significantly expand access to the blockbuster weight loss drug Wegovy for patients ... any patient who does not have insurance coverage for Wegovy or another ...